Shortages of name-brand obesity drugs like Wegovy and Zepbound led to a boom in compounded alternatives sold online. In a recent NPR report, AACE President Scott D. Isaacs, MD, FACP, FACE, cautioned that without FDA oversight, these products have not been proven safe or effective and may result in dosing errors.